The biological state of the tumour suppressor proteins Rb and p53 is altered in papillomavirus-and SV40-transformed cells, due to interaction with the DNA tumour virus oncogene proteins E6/E7 and the tumour (T) antigen. Thus, the DNA damage response function of p53, a crucial feature of the tumour suppressor p53, might be considered as inactive. To investigate this subject, C57SV and VLM, two SV40-transformed murine cell lines enharboring constitutively high nuclear p53 and SV40 large T antigen levels, were treated with mitomycin C. Mitomycin C is known for its activity to elicit DNA damage, followed by nuclear accumulation of biologically active p53. Surprisingly, the nuclear p53 level signi®cantly increased in mitomycin-C-treated C57SV cells and to a lesser degree in VLM cells. In addition, expression of p21WAF1 protein was induced in C57SV and VLM cells. This indicates a possible DNAdamage-elicited p53 activation. Finally, nuclear extracts of mitomycin-C-treated C57SV and VLM cells, but not of untreated cells, exhibited PAb421-enhanced speci®c DNA-binding activity of p53, as proven by gel shift analysis. Thus, DNA damage induced essential biological functions typical for wild-type p53 in the SV40-transformed cell lines examined so far.
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A conspicuous response of p53, particularly elicited by cancer treatment drugs, is the nuclear p53 accumulation. This reponse is weak in DNA-damaged myeloid and lymphoid cells (Kastan et al., 1991) , unless the cells have been pretreated with lectin, as observed for ConA-treated murine spleen cells (John, 1995) . In contrast, the DNA damage response is strong in various non-lymphoid rodent and primate cells (Fritsche et al., 1991 (Fritsche et al., , 1993 . Nevertheless, even these signi®cantly inducible p53 levels are low in comparison with those occurring constitutively in the nucleus of untreated SV40-transformed cells (Hess et al., 1994) .
Besides the role of p53 as an`indicator of chromatin injury' (Fritsche et al., 1991) by metabolic stabilization in the nucleus, and the implication for DNA replication and repair not discussed here, p53 induces the cell-cycle-associated protein p21WAF1 (see Zeng and El-Deiry, 1996) . In vitro p53 of nuclear extracts from DNA-damaged cells binds to speci®c DNA sequences assayed by gel shift retardation (Halazonetis et al., 1993) .
Induction by DNA damage of the above basal p53 functions seems rather unlikely in SV40-T-antigenexpressing transformed cells, since the conventional opinion is that the p53 is inactivated by the binding of the viral oncogene protein (see Alberts et al., 1994) . Consequently, SV40-T-antigen-expressing cells have been experimentally used as surrogate, instead of genuine genetically p53-defective cells (Caelles et al., 1994; Wahl et al., 1996) .
However, an examination, whether the above mentioned, DNA-damage-inducible p53 functions are silenced in SV40-transformed cells, has apparently not been described. Therefore, we have addressed this question. We have examined two SV40-transformed mouse cell lines, C57SV, a C57bl/6 non tumourigenic line (Knowles et al., 1979) and VLM, a tumourigenic BALB/c cell line (Zarling and Tevethia, 1973) . In comparison, the untransformed C3H10T1/2 mouse cell line (ATCC 226 CCL) was used as a wild-type p53 control cell line. The p53 DNA damage response of this cell line after treatment with mitomycin C, a DNA-damaging drug, has been studied previously (Plaumann et al., 1996; Siegel et al., 1995) .
We have treated the three cell lines with mitomycin C and have investigated (i), in the case of the SV40-transformed cells, the relative increase of p53, compared with SV40 T antigen, by double immunostaining of p53 and SV40 antigen; (ii), induction of p21WAF1; (iii) speci®c DNA-binding activity of p53, by gel shift assay.
Relative increase of p53, in comparison to the elevated SV40 T antigen levels, in mitomycin-C-treated C57SV and VLM cells Subcon¯uent cell cultures were prepared in Eagle's MEM with 3% fetal calf serum in 12-well dishes containing cover slips. DNA damage was generated by adding 15 mM mitomycin C for 18 h. To determine the relative levels of p53 and SV40 T antigen, the pertaining primary and secondary antibodies were mixed. SV40 T antigen was immunostained with the monoclonal murine antibody PAb1605 (Schoeel et al., 1988) , followed by¯uorescein-labelled anti murine Ig antibody. p53 was stained with polyclonal rabbit anti p53 serum under non-saturating conditions (obtained from D Lane, Dundee), followed by rhodamin-labelled anti rabbit Ig serum. The green (SV40 T antigen) and red (p53) immuno¯uorescence signals were evaluated simultaneously. To this end, the following Zeiss Axiophot microscope¯uorescence ®lters were used: exicitation, 485 nm (band width 20 nm) and 546 nm (band width 12 nm); dichroic beam splitter, 500/ 560 nm; emission 515 ± 530 nm and 580 ± 630 nm. Untreated cells showed a green-red combination colour. In contrast, in a fraction of cells from mitomycin-C-treated cultures the nuclei became red (the VLM cell less than the C57SV cells), indicating a signi®cant relative increase of`red' p53 above`green' SV40 T antigen (Figure 1, row A, C57SV , row B, VLM). This relative p53 increase indicates a DNA damage response which is typical for mitomycin-Ctreated C3H10T1/2 cells. (Plaumann et al., 1996; Siegel et al., 1995) . In the C3H10T1/2 control cells mitomycin C elicited p53 accumulation as expected (data not shown).
Nuclear accumulation of p21WAF1 protein in response to treatment with mitomycin C This protein was assayed in C57SV (Figure 1 , row C), VLM (row D), and C3H10T1/2 cells (row E) by immunostaining with polyclonal rabbit immunoglobulin (Oncogene Science cat. no. PC30, obtained from Dianova, Hamburg, Germany), followed by biotinlabelled anti rabbit immunoglobuline and streptavidinlabelled peroxidase/H 2 O 2 rhodamin-labelled tyramin, as instructed by the manufacturer of this TSADirect TM test kit (NEL702, from NEN, Homburg, Germany, assay kindly performed by Dr C Ihling, Institute of Pathology). As a result, in all three cell types the p21WAF1 levels increased after mitomycin C treatment. The following mean increase in the number of p21WAF1-positive nuclei was observed: C57SV, from 33 ± 55%; VLM, from 9 ± 23%, C3H10T1/2, from 45 ± 94%. This increase indicates that the induction of p21WAF1 after DNA damage is obviously not out of function in the SV40-transformed cells assayed so far. Interestingly, also VLM cells, in which the rise in the p53 level was less pronoucned after mitomycin C treatment, gave this p21WAF1 response. On the other hand, treatment with mitomycin C of genetically p53 knock-out earlypassage murine cells did not elicit induction of p21WAF1 (data not shown, Janson et al., 1997, in press ). However, p21WAF1 induction alone would not prove the causation by activated p53, since p21WAF expression can occur independently of p53 (reviewed by Zeng and El-Deiry, 1996) and independently of p53 mutation and expression, e.g. in human lung cancer cells (Mukhopadhyay and Roth, 1996) .
Speci®c interaction with DNA of nuclear p53 from mitomycin-C-treated C57SV and VLM cells arrow). Without PAb421, a retardation of the binary (p53/ 32 P-oligonucleotide) complex is distinctly visible with extract of mitomycin-C-treated C3H10T1/2 cells (single arrow). In the case of the transformed cells, mitomycin-C-treated or not, strong gel shift bands are visible, which migrate slightly faster than the corresponding band of the treated C3H10T1/2 cells. Therefore, the identity with p53 of the protein involved in these [ 32 P]oligonucleotide complexes formed in the absence (and, to a lesser degree, in the presence) of PAb421 is not sure as yet and has to be investigated. The relative amount of`supershifted' p53 in DNAdamaged C57SV cells is higher than in DNA-damaged VLM cells.
As a result, DNA damage elicited in the investigated SV40-transofmred cells the formation of p53 which is competent to generate a typical`supershift' in the retardation assay independently.
Several questions on the role of p53 in SV40-transformed cells still remain unsolved. Thus, as so far investigated, SV40-transformed cells contain stabilized nuclear p53 in at least two forms. But only one type forms a complex with SV40 T antigen (Deppert and Haug, 1983; Goldberg et al., 1992 . It is open, whether both these forms of p53 were activated or only the form not binding to T antigen, in addition to the possibly newly accumulated p53, which has been translated after the DNA damage. p53 complexed with SV40 T antigen was observed not to have lost speci®c DNA-binding ability (Long et al., 1995) .
Thus, even the constitutively elevated levels of wildtype p53 in transformed cells further increased after DNA damage. This is in accordance with our previous observation that the constitutively elevated level of the nuclear wild-type p53 of murine teratocarcinoma F9 cells was increased after DNA damage by adriamycin, cisplatin,¯uorouracil, mitomycin C, etoposide, or U.V. C light (Knoblich, 1993) . Furthermore, DNA damage activates p53 in murine teratocarcinoma cells (Lutzker and Levine, 1996) . Thus, p53 is silent in the investigated teratocarcinoma and SV40-transformed cells, despite being present in elevated nuclear level; however, it can be activated by DNA damage.
DNA damage is obviously essential for the observed increase of p21WAF1 protein. However, even without DNA damage a fraction of the transformed and untransformed murine cells of this study exhibited nuclear p21WAF1 protein (see Figure  1c ± e). Also in human SV40-transformed and in senescent, untransformed cells upregulation of p21WAF1 expression was detected (Tahara et al., 1995) , whereas in a SV40-transfected rat cell line no signi®cant levels of p21WAF1 mRNA were found (Lenahan and Ozer, 1996) . Similarly, it depends on the cellular background, whether the presence or the absence of wild-type p53 in a tumour cell line is associated with a`normal' DNA damage/apoptosis response, and a defective p53 may not necessarily prevent the chemosensitivity of tumours (see Delia et al., 1996; Wu and El-Deiry, 1996) .
In conclusion, signi®cant p53 functions (DNAdamage-inducible accumulation, p21WAF1 induction; and sequence-speci®c DNA interaction of p53 after DNA damage) are intact in the SV40-transformed cells examined so far. It still remains to be investigated whether the residual activity of p53 in SV40-transformed cells is a feature of murine cells or occurs also in cells from other vertebrates, especially of human origin. Remarkably, also in human papillomavirus-transformed cells basal DNA-damage-inducible p53 functions are intact (Butz et al., 1995) and the high-risk papillomavirus type 16 E6 gene product promotes the cell cycle per se in cervical cancer cells (Spitkovsky et al., 1996) .
Thus, in spite of the interaction of viral oncogene proteins, p53 remains inducible by DNA damage and can be activated in the papovavirus-transformed cell lines investigated so far. 16.1) and Foundation MuÈ ller-Fahnenberg.
--+ + --+ -+ + -+ -+ -+ + + -+ C3H10T1/2 VLM C57SV Mit. C PAb421 Figure 2 Gel shift assay of nuclear p53 extracted from untreated and mitomycin-C-treated (Mit C) C57SV, VLM, and C3H10T1/2 cells binding to 32 P-labelled oligonucleotide in gel retardation assay according to Halazonetis et al. (1993) , incubated in the absence (7) or presence (+) of PAb421, generating a p53-[ 
